Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort
- PMID: 24235929
- PMCID: PMC3824501
- DOI: 10.4314/ahs.v13i2.16
Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort
Abstract
Background: Although good adherence to antiretroviral therapy (ART) is essential for successful treatment outcomes, some patients may have specific personal barriers to ART adherence.
Objectives: To study specific personal barriers to ART adherence.
Methods: Quantitative data on patients' health status, ART adherence, CD4 cell counts and viral loads were collected, and qualitative data on life experiences of five patients with poor ART outcomes and adherence were also collected.
Results: Out of 35 patients with poor immunological and virological ART outcomes, 17 (49%) also had poor ART adherence. Patient 1 had no living child and did not disclose her HIV serostatus to her spouse because she wanted to have a child. Patient 2 was an orphan with neither social nor family support. Patient 3 stopped ART when she conceived, returned to the study clinic when pregnant again and was sickly. She was switched to second-line ART with satisfactory outcomes. Patient 4, a 14 year old orphan had missed ART for 2 months when his treatment supporter was away. Patient 5 aged 66 years stopped ART which he blamed for his erectile dysfunction.
Conclusion: ART adherence counselling should target specific personal barriers to ART adherence like: lack of family support, health and sexual life concerns, desire to have children and family instability.
Keywords: ART adherence; Personal barriers; children desire; disclosure; sexual dysfunction; stigma.
References
-
- Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13(Suppl 2):1–13. - PubMed
-
- WHO/UNAIDS/UNICEF, author. Progress Report 2011. Geneva: WHO; 2011. Global HIV/AIDS response - Epidemic update and health sector progress towards Universal Access.
-
- Division of global HIV/AIDS (DGHA) CfDCaP, author. Global HIV/AIDS, HIV/AIDS in Uganda. 2012. http://www.cdc.gov/globalaids/Global-HIV-AIDS-at-CDC/countries/Uganda/.
-
- Hirschel B, Opravil M. The year in review: antiretroviral treatment. AIDS. 1999;13(Suppl A):S177–S187. - PubMed
-
- Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W, et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group. AIDS. 1998 Jan 22;12(2):167–173. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials